XML 43 R7.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Consolidated Statement of Stockholders' Equity - USD ($)
$ in Millions
Total
Common Stock
Other Paid-in Capital:
Retained Earnings:
Deferred Retirement Benefit Costs
Accumulated Other Comprehensive Loss:
Total Shareholders’ Equity
Noncontrolling Interests:
Union Electric Company
Union Electric Company
Common Stock
Union Electric Company
Other Paid-in Capital:
Union Electric Company
Preferred Stock
Union Electric Company
Retained Earnings:
Ameren Illinois Company
Ameren Illinois Company
Common Stock
Ameren Illinois Company
Other Paid-in Capital:
Ameren Illinois Company
Preferred Stock
Ameren Illinois Company
Retained Earnings:
Beginning of period at Dec. 31, 2022     $ 6,860 $ 3,646 $ (1)     $ 129     $ 2,725   $ 3,111         $ 3,190
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Shares issued under the DRPlus and 401(k) plan     23                              
Stock-based compensation activity     (3)                              
Net income $ 504               $ 132       132 $ 328       328
Net income attributable to Ameren common shareholders 501     501                            
Dividends on common stock       (330)                           0
Preferred stock dividends                         (2)         (1)
Change in deferred retirement benefit costs (2)       (2)                          
Net income attributable to noncontrolling interest holders $ (3)             3                    
Dividends paid to noncontrolling interest holders               (3)                    
Common stock shares outstanding at beginning of period at Dec. 31, 2022 262,000,000.0                                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Shares issued under the DRPlus and 401(k) plan 200,000                                  
Shares issued for stock-based compensation 500,000                                  
Common stock shares outstanding at end of period at Jun. 30, 2023 262,700,000                                  
End of period at Jun. 30, 2023 $ 10,826 $ 3 6,880 3,817 (3) $ (3)   129   $ 511 2,725 $ 80 3,241   $ 0 $ 2,929 $ 49 3,517
Shareholders' equity, end of year at Jun. 30, 2023             $ 10,697   6,557         6,495        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Dividends per common share $ 1.26                                  
Beginning of period at Mar. 31, 2023     6,861 3,745 (2)     129     2,725   3,139         3,388
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Shares issued under the DRPlus and 401(k) plan     11                              
Stock-based compensation activity     8                              
Net income $ 239               103       103 130       130
Net income attributable to Ameren common shareholders 237     237                            
Dividends on common stock       (165)                           0
Preferred stock dividends                         (1)         (1)
Change in deferred retirement benefit costs (1)       (1)                          
Net income attributable to noncontrolling interest holders $ (2)             2                    
Dividends paid to noncontrolling interest holders               (2)                    
Common stock shares outstanding at beginning of period at Mar. 31, 2023 262,600,000                                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Shares issued under the DRPlus and 401(k) plan 100,000                                  
Shares issued for stock-based compensation 0                                  
Common stock shares outstanding at end of period at Jun. 30, 2023 262,700,000                                  
End of period at Jun. 30, 2023 $ 10,826 3 6,880 3,817 (3) (3)   129   511 2,725 80 3,241   0 2,929 49 3,517
Shareholders' equity, end of year at Jun. 30, 2023             10,697   $ 6,557         $ 6,495        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Dividends per common share $ 0.63                                  
Beginning of period at Dec. 31, 2023 $ 11,478   7,216 4,136 (6)     129     2,725   3,647         3,756
Common stock shares outstanding at beginning of period at Dec. 31, 2023 266,300,000               102,100,000         25,500,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Shares issued for stock-based compensation 200,000                                  
Common stock shares outstanding at end of period at Mar. 31, 2024 266,600,000                                  
End of period at Mar. 31, 2024     7,228 4,219 (7)     129     2,725   3,672         3,971
Beginning of period at Dec. 31, 2023 $ 11,478   7,216 4,136 (6)     129     2,725   3,647         3,756
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Shares issued under the DRPlus and 401(k) plan     21                              
Stock-based compensation activity     9                              
Net income 522               $ 155       155 $ 340       340
Net income attributable to Ameren common shareholders 519     519                            
Dividends on common stock       (356)                           (25)
Preferred stock dividends                         (2)         (1)
Change in deferred retirement benefit costs (3)       (3)                          
Net income attributable to noncontrolling interest holders $ (3)             3                    
Dividends paid to noncontrolling interest holders               (3)                    
Common stock shares outstanding at beginning of period at Dec. 31, 2023 266,300,000               102,100,000         25,500,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Shares issued under the DRPlus and 401(k) plan 300,000                                  
Shares issued for stock-based compensation 200,000                                  
Common stock shares outstanding at end of period at Jun. 30, 2024 266,800,000               102,100,000         25,500,000        
End of period at Jun. 30, 2024 $ 11,668 3 7,246 4,299 (9) (9)   129   511 3,075 80 3,800   0 3,020 49 4,070
Shareholders' equity, end of year at Jun. 30, 2024 $ 11,539           11,539   $ 7,466         $ 7,139        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Dividends per common share $ 1.34                                  
Beginning of period at Mar. 31, 2024     7,228 4,219 (7)     129     2,725   3,672         3,971
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Shares issued under the DRPlus and 401(k) plan     11                              
Stock-based compensation activity     7                              
Net income $ 260               $ 129       129 $ 125       125
Net income attributable to Ameren common shareholders 258     258                            
Dividends on common stock       (178)                           (25)
Preferred stock dividends                         (1)         (1)
Change in deferred retirement benefit costs (2)       (2)                          
Net income attributable to noncontrolling interest holders $ (2)             2                    
Dividends paid to noncontrolling interest holders               (2)                    
Common stock shares outstanding at beginning of period at Mar. 31, 2024 266,600,000                                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Shares issued under the DRPlus and 401(k) plan 200,000                                  
Shares issued for stock-based compensation 0                                  
Common stock shares outstanding at end of period at Jun. 30, 2024 266,800,000               102,100,000         25,500,000        
End of period at Jun. 30, 2024 $ 11,668 $ 3 $ 7,246 $ 4,299 $ (9) $ (9)   $ 129   $ 511 $ 3,075 $ 80 $ 3,800   $ 0 $ 3,020 $ 49 $ 4,070
Shareholders' equity, end of year at Jun. 30, 2024 $ 11,539           $ 11,539   $ 7,466         $ 7,139        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Dividends per common share $ 0.67